Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.4458 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)[C@@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
InChI
InChIKey=JGMOKGBVKVMRFX-POHNSKBLSA-N
InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17-,18-,19+,20+,21+/m0/s1
9β,10α,17α-pregna-4,6-diene-3,20-dione ((8S,9R,10S,13S,14S,17R)-17-Acetyl-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one) is an isomer of Dydrogesterone, a synthetic progestin largely used in hormone therapy, on the central nervous system by studying two markers of the neuroendocrine function. 9β,10α,17α-pregna-4,6-diene-3,20-dione is one of major impurities of dydrogesterone. The physiological and toxicological properties of this compound have not been evaluated in humans.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
S48G465CS3
Created by
admin on Mon Mar 31 21:20:27 GMT 2025 , Edited by admin on Mon Mar 31 21:20:27 GMT 2025
|
PRIMARY | |||
|
246038-13-1
Created by
admin on Mon Mar 31 21:20:27 GMT 2025 , Edited by admin on Mon Mar 31 21:20:27 GMT 2025
|
PRIMARY | |||
|
DTXSID70179353
Created by
admin on Mon Mar 31 21:20:27 GMT 2025 , Edited by admin on Mon Mar 31 21:20:27 GMT 2025
|
PRIMARY | |||
|
1547487
Created by
admin on Mon Mar 31 21:20:27 GMT 2025 , Edited by admin on Mon Mar 31 21:20:27 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
